Ramucirumab | Interleukin Related interleukin-related.com

Product Name :
Ramucirumab

Search keywords :
Ramucirumab

drugId :
null

Target Vo:
Vascular endothelial growth factor receptor 2

Target Vo Short Name :
VEGFR2

Moa_Name:
Vascular endothelial growth factor receptor 2 antagonists

First Approval Country :
United States

First Approval Date Filter:
2014

Origin Company_Name :
Dyax Pharma

Active Company_Name :
Dana-Farber Cancer Institute

Active Indication_Name:
Carcinoma, Hepatocellular

In Active Indication_Name:
Peritoneal Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AMPK alpha 1 Rabbit pAb manufacturer
Adintrevimab Anti-infection
CD40 Antibody: CD40 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 31 kDa, targeting to CD40. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts